HomeNDC LookupRxCUI directory › RxCUI 835831

Testosterone cypionate 100 MG/ML Injectable Solution [Depo-testosterone] — RxCUI 835831

RxNorm drug concept · Semantic branded drug
RxCUI 835831 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 6 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI835831
Official nameTestosterone cypionate 100 MG/ML Injectable Solution [Depo-testosterone]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDepo-testosterone 100 MG/ML Injectable Solution
FDA products mapped5
Package NDCs mapped6
Reported Medicaid activity (SDUD)11,655 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Testosterone Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Testosterone gel is a hormone replacement therapy for adult men whose bodies don't produce enough testosterone on their own — a condition called hypogonadism. This can happen becau...
  • What exactly is testosterone gel used for?
  • Yes, location really matters. Testosterone gel 1.62% goes on the shoulders and upper arms only — not the abdomen, chest, genitals, armpits, or knees. Apply it to clean, dry, unbrok...
  • How do I apply it correctly, and does it matter where I put it?
📖 Read our full Testosterone Transdermal Patch guide →

🕸️ Concept Web — How Testosterone cypionate 100 MG/ML Injectable Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Testosterone cypionate 100 MG/ML Injectable Solution [Depo-testosterone] RxCUI 835831

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Testosterone 10379
    • Testosterone cypionate 835827
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Depo-testosterone 48877
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Testosterone Injectable Solution 374050
    • Testosterone cypionate Injectable Solution 2648605
    • Testosterone Injectable Product 1164841
    • Testosterone cypionate Injectable Product 2663142
    • Testosterone Injectable Solution [Depo-testosterone] 363347
    • Testosterone cypionate Injectable Solution [Depo-testosterone] 2657414
    • Depo-testosterone Injectable Product 1173115
    • Injectable Solution 316949
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Testosterone cypionate 100 MG/ML Injectable Solution SCD · 835829
  • Testosterone cypionate 100 MG/ML SCDC · 835828
  • Testosterone Injectable Solution SCDF · 374050
  • Testosterone cypionate Injectable Solution SCDFP · 2648605
  • Testosterone Injectable Product SCDG · 1164841
  • Testosterone cypionate Injectable Product SCDGP · 2663142

Brand-Name Concepts

  • Testosterone cypionate 100 MG/ML [Depo-testosterone] SBDC · 835830
  • Testosterone Injectable Solution [Depo-testosterone] SBDF · 363347
  • Testosterone cypionate Injectable Solution [Depo-testosterone] SBDFP · 2657414
  • Depo-testosterone Injectable Product SBDG · 1173115
  • Depo-testosterone BN · 48877

📦 FDA Products & Package NDCs

5 products · 6 package NDCs
6 package NDCs map to RxCUI 835831 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0085-10 1 VIAL in 1 CARTON (0009-0085-10) / 10 mL in 1 VIAL Depo-Testosterone Pharmacia & Upjohn Company LLC 2014-07-01
00009-0086-01 1 VIAL in 1 CARTON (0009-0086-01) / 1 mL in 1 VIAL Depo-Testosterone Pharmacia & Upjohn Company LLC 2014-07-01
00009-0347-02 1 VIAL in 1 CARTON (0009-0347-02) / 10 mL in 1 VIAL Depo-Testosterone Pharmacia & Upjohn Company LLC 1979-07-25
00009-0417-01 1 VIAL in 1 CARTON (0009-0417-01) / 1 mL in 1 VIAL Depo-Testosterone Pharmacia & Upjohn Company LLC 1979-07-25
00009-0417-02 1 VIAL in 1 CARTON (0009-0417-02) / 10 mL in 1 VIAL Depo-Testosterone Pharmacia & Upjohn Company LLC 1979-07-25
76420-0425-10 1 VIAL in 1 CARTON (76420-425-10) / 10 mL in 1 VIAL Depo-Testosterone Asclemed USA, Inc. 2025-08-08
Observed labelers: Pharmacia & Upjohn Company LLC (5) · Asclemed USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1071 Inj testosterone cypionate 5 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.